Is Arvee Laboratories (India) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Arvee Laboratories (India) Ltd is a average quality company .

Is Arvee Laboratories (India) undervalued or overvalued?

The key valuation ratios of Arvee Laboratories (India) Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Arvee Laboratories (India) share price return in the past 10 years?

Data is not available for this company

Is Arvee Laboratories (India) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Arvee Laboratories (India) Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the P/E ratio of Arvee Laboratories (India)?

The latest standalone P/E ratio of Arvee Laboratories (India) as of 01-Jan-1970 is 291.36.

What is the P/B ratio of Arvee Laboratories (India)?

The latest standalone P/B ratio of Arvee Laboratories (India) as of 01-Jan-1970 is 9.50.

Arvee Laboratories (India) Ltd - Stock Valuation and Financial Performance

Name: Arvee Laboratories (India)
Brand: Arvee Laboratories (India)

BSE: 0 | NSE: ARVEE | Chemicals | Small Cap

Place order

BSE Share Price
Not Listed

10 Year X-Ray of Arvee Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	9.6%	0.4%	9.3%	14%	11.5%	11.4%	11%	11.7%	9.7%	12.8%	-
Value Creation Index ⓘ	-0.3	-1.0	-0.3	-0	-0.2	-0.2	-0.2	-0.2	-0.3	-0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	11.8	13	26.8	34.4	47.8	54.9	45.4	47.4	40.3	61.4	37
Sales YoY Gr.	-	9.9%	106.8%	28.3%	38.8%	14.9%	-17.3%	4.3%	-14.9%	52.1%	-
Adj EPS ⓘ	0	-2.8	0.2	1.9	1	2.1	2	2.5	2.3	3	0.9
YoY Gr.	-	-9266.7%	NA	734.8%	-48.4%	107.1%	-4.4%	25%	-6.5%	31.9%	-
BVPS (₹) ⓘ	5.1	2.4	3.3	5.2	12.7	14.8	16.9	19.4	21.7	25.5	26.3
Adj Net Profit ⓘ	0	-1.7	0.2	1.6	1.1	2.3	2.2	2.7	2.5	3.3	1
Cash Flow from Ops. ⓘ	-0.3	8.6	6.2	4	6	9.5	10.3	1.7	4	2.9	-
Debt/CF from Ops. ⓘ	-43.7	2.4	4.1	6.2	2.7	1.4	0.4	5.2	0.8	0.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	20.1%	5.1%	10.5%	52.1%
Adj EPS ⓘ	66.9%	25%	15.5%	31.9%
BVPSⓘ	19.6%	15%	14.6%	17.2%
Share Price	-	31.7%	38.3%	100.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	1.2	-73.6	9.2	45.4	11.8	14.8	12.2	13.4	11.1	12.8	3.3
Op. Profit Mgn % ⓘ	15.4	16.1	17.5	16.3	15	11.3	13.3	12.8	14	11.9	9.1
Net Profit Mgn % ⓘ	0.2	-12.7	0.7	4.5	2.3	4.1	4.7	5.7	6.3	5.4	2.6
Debt to Equity ⓘ	4.4	14.7	9.6	6	1.2	0.8	0.2	0.4	0.1	0	-
Working Cap Days ⓘ	209	266	187	182	167	140	124	123	167	127	92
Cash Conv. Cycle ⓘ	83	132	70	83	64	53	33	25	53	43	64

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 10.54%

Net Profit is growing at healthy rate in last 3 years 15.50%

Return on Equity has declined versus last 3 years average to 3.30%

Sales growth is not so good in last 4 quarters at -43.11%

Latest Financials - Arvee Laboratories (India) Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.9	-
TTM Sales (₹ Cr.)	36.8	-
BVPS (₹.) ⓘ	26.3	-
Reserves (₹ Cr.) ⓘ	18	-
P/BV ⓘ	9.50	-
PE ⓘ	291.36	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	275
Equity (₹ Cr.)	11
Face Value (₹)	10
Industry PE ⓘ	48.3

Management X-Ray of Arvee Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Arvee Laboratories

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Arvee Laboratories

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	12	13	27	34	48	55	45	47	40	61
Operating Expenses ⓘ	10	11	22	29	41	49	39	41	35	54
Manufacturing Costs	1	1	2	3	5	4	3	3	3	5
Material Costs	7	7	17	22	30	39	29	29	22	39
Employee Cost	1	2	2	3	3	3	3	6	6	6
Other Costs ⓘ	1	1	1	1	3	3	4	3	3	4
Operating Profit ⓘ	2	2	5	6	7	6	6	6	6	7
Operating Profit Margin (%)	15.3%	16.1%	17.5%	16.3%	15.0%	11.2%	13.3%	12.7%	13.9%	11.9%
Other Income ⓘ	0	0	0	1	0	0	0	1	1	1
Interest ⓘ	2	2	3	3	3	2	1	1	0	0
Depreciation ⓘ	0	1	1	2	2	2	2	2	2	2
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	-1	1	1	2	3	3	4	3	6
Tax ⓘ	0	1	0	-1	1	0	1	1	1	2
Profit After Tax	0	-2	0	2	1	2	2	3	3	4
PAT Margin (%)	0.2%	-12.7%	0.7%	4.5%	2.3%	4.1%	5.1%	5.7%	6.4%	6.7%
Adjusted EPS (₹)	0.0	-2.8	0.2	1.9	1.0	2.1	2.1	2.4	2.3	3.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	3	1	3	4	14	16	19	21	24	28
Share Capital ⓘ	3	3	4	4	6	6	6	11	11	11
Reserves ⓘ	0	-2	-1	0	9	11	13	10	13	17
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	13	21	24	24	15	11	4	9	3	1
Long Term Debt	8	15	17	17	8	3	2	1	1	1
Short Term Debt	5	6	6	7	7	8	2	8	2	0
Trade Payables	1	3	6	6	12	6	10	10	10	8
Others Liabilities ⓘ	0	1	3	2	3	3	1	1	2	2
Total Liabilities ⓘ	17	26	35	36	44	37	34	41	39	39
Fixed Assets
Gross Block	2	10	16	21	22	22	24	27	30	31
Accumulated Depreciation	0	1	2	4	7	9	11	14	16	18
Net Fixed Assetsⓘ	2	9	13	17	15	13	13	14	14	13
CWIP ⓘ	7	5	4	0	1	2	2	1	1	2
Investmentsⓘ	0	0	0	0	0	2	3	2	0	0
Inventories	3	6	7	6	8	5	6	7	6	5
Trade Receivables	3	2	6	8	15	8	7	8	12	12
Cash Equivalents	0	1	1	1	2	4	1	7	5	1
Others Assetsⓘ	2	3	3	3	2	4	2	2	1	7
Total Assets ⓘ	17	26	35	36	44	37	34	41	39	39

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0	9	6	4	6	9	10	2	4	3
PBT ⓘ	0	-1	1	1	2	3	3	4	3	6
Adjustment ⓘ	2	3	4	5	5	3	3	2	2	2
Changes in Working Capital ⓘ	-2	6	1	-3	-1	4	5	-3	-1	-4
Tax Paid ⓘ	0	0	0	1	-1	0	-1	-1	-1	-2
Cash Flow From Investing Activity ⓘ	-6	-6	-5	-1	-1	-3	-3	-1	0	-1
Capex	-6	-6	-5	-1	-1	-2	-2	-2	-2	-1
Net Investments	0	0	0	0	0	-2	-1	1	2	0
Others ⓘ	0	0	0	0	0	1	0	1	0	0
Cash Flow From Financing Activityⓘ	7	-2	-1	-3	-4	-5	-10	5	-6	-2
Net Proceeds from Shares ⓘ	3	0	1	0	9	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	3	-9	-4	0	-1	-6	0
Interest Paid ⓘ	-2	-2	-3	-3	-3	-1	-1	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	5	0	1	-3	-1	1	-9	6	0	-2
Net Cash Flow ⓘ	0	1	0	0	1	2	-3	6	-2	-1

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	1.19	-73.58	9.24	45.41	12.01	14.97	13.17	13.38	11.36	15.84
ROCE (%)	13.64	7.51	14.39	15.19	17.69	14.1	15.79	15.99	13.33	23.35
Asset Turnover Ratio	0.9	0.6	0.88	0.97	1.2	1.35	1.28	1.27	1.01	1.59
PAT to CFO Conversion(x)	N/A	N/A	N/A	2	6	4.5	5	0.67	1.33	0.75
Working Capital Days
Receivable Days	67	64	52	76	91	78	58	55	91	73
Inventory Days	54	131	91	70	55	42	45	54	60	31
Payable Days	57	92	97	99	111	85	100	121	158	82

Arvee Laboratories (India) Ltd Stock News

Arvee Laboratories (India) Ltd FAQs

What is the share price of Arvee Laboratories?

Company share prices are keep on changing according to the market conditions. The closing price of Arvee Laboratories on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Arvee Laboratories?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Arvee Laboratories stood at ₹275.3.